• SENSEX
    NIFTY 50
Healthcare

India's Hetero wins approval to launch COVID-19 drug favipiravir

Updated : July 29, 2020 12:35 PM IST

The drug, priced at 59 rupees (79 cents) per tablet, is approved to treat mild to moderate COVID-19 and will be available at drug stores from Wednesday, privately held Hetero said in a statement.
Favipiravir and another anti-viral treatment, remdesivir, have emerged as the most sought after medicines to treat COVID-19 in India.
India's Hetero wins approval to launch COVID-19 drug favipiravir

You May Also Like

Live TV
Advertisement